Journal profile

World journal of surgical oncology

Publisher: BioMed Central
ISSN1477-7819 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.88
Citation rate 3.53 2,452 total citations
h5-index 43 h5 depth signal
Cited share 82.6% 618 of 748
Total citations 2,452 Citation footprint
Metric signal 3.59 External metric anchor
Self-citation 2.1% 52 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 2,457
Japan 390
United States 135
South Korea 107
Germany 104

Citing Fields of Research

Oncology 941
Liver & Colon Cancer 840
Digestive Disorders 652
Abdominal Surgery 558
Breast Cancer 379

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 6,073 Articles tracked across the journal lifetime
Indexed publication set 748 618 cited publications
Last 12 months 575 47.9 publications/month
Open access share 100.0% 575 OA publications in the last year
Leading citing country China 2,457 citing publications
Leading citing field Oncology 941 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v5, 2007-
PubMed
v1n1,2003-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Oncology Liver & Colon Cancer Digestive Disorders Breast Cancer Lung Cancer Musculoskeletal & Nerve Cancer

Broad Categories

General Surgery Neoplasms Digestive Disorders Liver & Colon Cancer Lung Cancer Musculoskeletal & Nerve Cancer Reproductive Health Breast Cancer

MeSH Descriptors

Neoplasms Neoplasms Surgical Procedures, Operative

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

05
Shigeki Matsubara
Concerns have recently been raised that AI-assisted “letter-bombing” may distort medical publishing. Although I share these concerns, prolific
07
Chenxi Wang, Xiangqian Zhao, Zhihua Feng et al.
Background and purpose: Super elderly patients (aged ≥ 85 years) with triple-negative breast cancer (TNBC) are markedly underrepresented in clinical trials. The survival benefit of adjuvant radiotherapy (RT) in this population remains un...

Bibliographical & Catalog Notes

Title from home page (viewed May 28, 2003).

Last issue consulted: Vol. 1, issue 5 (7 May 2003) (viewed May 28, 2003).

Articles added consecutively to current annual v.

Mode of access: Internet.